Phenytoin

Phenytoin Full Name

Phenytoin

Phenytoin Introduction

Phenytoin is a well-established small-molecule anticonvulsant that continues to draw attention not only for seizure control but also for its expanding therapeutic potential in tissue repair and regenerative medicine. For many clinicians and researchers, a persistent challenge lies in understanding how a decades-old drug can remain clinically relevant while being repositioned into new indications. At the molecular level, phenytoin primarily targets voltage-gated sodium channels (Nav), stabilizing neuronal membranes by prolonging the inactivated state of these channels and thereby reducing repetitive neuronal firing. Beyond this canonical mechanism, emerging evidence shows that phenytoin also modulates L-type calcium channels, enhances inhibitory signaling through GABA_A receptors, and exhibits anti-inflammatory effects, all of which contribute to its broader pharmacological profile. Its metabolism via CYP2C9 and CYP2C19 introduces nonlinear pharmacokinetics, meaning that even small dose adjustments can significantly alter plasma concentrations—an important consideration for both safety and efficacy in clinical settings.

From a functional perspective, phenytoin's biological activity extends far beyond neuronal excitability, addressing a key unmet need in wound management: accelerating tissue repair while minimizing complications. Recent studies have demonstrated that topical phenytoin can significantly enhance wound healing by promoting fibroblast proliferation, collagen deposition, and angiogenesis. It also appears to exert antimicrobial effects, particularly against Gram-negative bacteria, and provides localized analgesic benefits, making it highly attractive for chronic or difficult-to-heal wounds. Innovative delivery systems, such as polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP)-based self-healing hydrogels, as well as mucoadhesive wafers incorporating biodegradable polymers like alginate and chitosan, have further improved its therapeutic performance. These systems enable controlled drug release and improved tissue adherence, addressing common limitations in traditional wound care formulations and offering more consistent healing outcomes in both preclinical and clinical models.

In terms of disease relevance, phenytoin remains a cornerstone in the management of epilepsy, particularly for focal and generalized tonic-clonic seizures, where its sodium channel-blocking activity directly counteracts the hyperexcitability underlying these conditions. However, its repositioning into wound care highlights its value in addressing chronic ulcers, burn injuries, and post-surgical wounds—areas where delayed healing poses significant risks to patients and healthcare systems alike. Experimental and clinical data indicate that phenytoin-treated wounds show enhanced epithelialization, improved dermal organization, and even regeneration of skin appendages such as hair follicles. This dual relevance—neurological stabilization and tissue regeneration—positions phenytoin as a unique pharmacological bridge between neuroscience and regenerative medicine. As research continues to refine delivery strategies and uncover deeper molecular mechanisms, phenytoin is increasingly recognized not just as an anticonvulsant, but as a multifunctional therapeutic agent with significant translational potential.

Alternate Names for Phenytoin

5 5 diphenyl 2 4 imidazolidinedione; 55 diphenyl 24 imidazolidinedione; Dilantin; Diphenylhydantoin; Epanutin; Phenytek; Phenytoin

• Small Molecule Drug Monitoring
• Small Molecule Drug Monitoring
• Small Molecule Drug Monitoring
• Small Molecule Drug Monitoring
• Small Molecule Drug Monitoring
• Small Molecule Drug Monitoring

• 1.Machado-Torres K, et al.; Self-healing PVA/PVP micelle-hydrogel composite system for potential phenytoin repositioning in wound healing. J Biol Eng. 2025, 20(1):6.
  2.Jones GL, et al.; Phenytoin: basic and clinical pharmacology. Med Res Rev. 1983, 3(4):383-434.